526 related articles for article (PubMed ID: 16426869)
41. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study.
Misra UK; Kalita J; Maurya PK
J Neurol; 2012 Apr; 259(4):645-8. PubMed ID: 21898137
[TBL] [Abstract][Full Text] [Related]
42. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
Cilio MR; Bianchi R; Balestri M; Onofri A; Giovannini S; Di Capua M; Vigevano F
Epilepsy Res; 2009 Sep; 86(1):66-71. PubMed ID: 19520548
[TBL] [Abstract][Full Text] [Related]
43. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
44. Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.
Fattouch J; Di Bonaventura C; Casciato S; Bonini F; Petrucci S; Lapenta L; Manfredi M; Prencipe M; Giallonardo AT
Acta Neurol Scand; 2010 Jun; 121(6):418-21. PubMed ID: 20578996
[TBL] [Abstract][Full Text] [Related]
45. Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.
Weber P
J Child Neurol; 2010 Mar; 25(3):393-6. PubMed ID: 19605773
[TBL] [Abstract][Full Text] [Related]
46. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Delanty N; Jones J; Tonner F
Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
[TBL] [Abstract][Full Text] [Related]
47. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
Friedman D; French JA
Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
[TBL] [Abstract][Full Text] [Related]
48. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.
Swisher CB; Doreswamy M; Gingrich KJ; Vredenburgh JJ; Kolls BJ
Neurocrit Care; 2012 Feb; 16(1):109-13. PubMed ID: 21882056
[TBL] [Abstract][Full Text] [Related]
49. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study.
Nene D; Mundlamuri RC; Satishchandra P; Prathyusha PV; Nagappa M; Bindu PS; Raghavendra K; Saini J; Bharath RD; Thennarasu K; Taly AB; Sinha S
Seizure; 2019 Feb; 65():111-117. PubMed ID: 30682680
[TBL] [Abstract][Full Text] [Related]
50. Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs.
Wychowski T; Wang H; Buniak L; Henry JC; Mohile N
Clin Neurol Neurosurg; 2013 Nov; 115(11):2365-9. PubMed ID: 24054994
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N
Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
[TBL] [Abstract][Full Text] [Related]
52. [The value of an oral solution of levetiracetam in status epilepticus].
Pato-Pato A; Raña-Martínez N; Lorenzo-González JR; Cimas-Hernando I
Rev Neurol; 2006 Jun 16-30; 42(12):768. PubMed ID: 16775807
[No Abstract] [Full Text] [Related]
53. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
54. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
Burakgazi E; Bashir S; Doss V; Pellock J
Clin EEG Neurosci; 2014 Apr; 45(2):89-91. PubMed ID: 24357676
[TBL] [Abstract][Full Text] [Related]
55. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
Kinirons P; McCarthy M; Doherty CP; Delanty N
Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
[TBL] [Abstract][Full Text] [Related]
56. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
[TBL] [Abstract][Full Text] [Related]
57. Levetiractam in the treatment of two children with myoclonic status epilepticus.
Haberlandt E; Sigl SB; Scholl-Buergi S; Karall D; Rauchenzauner M; Rostásy K
Eur J Paediatr Neurol; 2009 Nov; 13(6):546-9. PubMed ID: 19010072
[TBL] [Abstract][Full Text] [Related]
58. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
60. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
Alvarez V; Januel JM; Burnand B; Rossetti AO
Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
